Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- manufacturers
- ASN90
-
- $2680.00
-
2026-05-19
- CAS:1884154-02-2
- Purity:
- Supply Ability: 10g
|
| | Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- Basic information |
| Product Name: | Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- | | Synonyms: | Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]-;ASN 90;(S)-N-(5-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-1-yl)-1,3,4-thiadiazol-2-yl)acetamide | | CAS: | 1884154-02-2 | | MF: | C17H21N5O3S | | MW: | 375.45 | | EINECS: | | | Product Categories: | | | Mol File: | 1884154-02-2.mol | ![Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- Structure](CAS/20210305/GIF/1884154-02-2.gif) |
| | Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- Chemical Properties |
| density | 1.398±0.06 g/cm3(Predicted) | | pka | 9.43±0.50(Predicted) | | form | Solid | | color | Light yellow to light brown |
| | Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- Usage And Synthesis |
| Uses | Egalognastat is a specific and orally active O-GlcNAcase (OGA) enzyme inhibitor with IC50 value of 10.2 nM. Egalognastat can be used for the research of neurodegenerative diseases, such as tauopathies and α-synucleinopathies[1]. | | References | [1] Permanne B, et al. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies. ACS Chem Neurosci. 2022 Apr 20;13(8):1296-1314. DOI:10.1021/acschemneuro.2c00057 |
| | Acetamide, N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]-1-piperazinyl]-1,3,4-thiadiazol-2-yl]- Preparation Products And Raw materials |
|